A-Cube
34th A-Cube® Research Test Seminar Announcement
The 34th A-Cube® Research Test Seminar will be hel…
NEWS Index
NEWS
ProteoBridge Inc. Representative Appointed as Director of the Japan Bioinformatics Consortium (JBIC)
ProteoBridge Inc. (Head Office: Koto-ku, Tokyo) is…
A-Cube
Our Technology Featured in Allergy & Rheumatic Diseases September 2025 Issue – Special Feature on “Allergen Immunotherapy”
In the September 2025 issue of Allergy & Rheum…
A-Cube
🎉 The 11th Annual Meeting of the Japanese Society of Myology Has Officially Begun!
At our booth, we are showcasing a wide range of se…
HuPEX
HuPEX®-Powered Proteomics Research Published in Journal of Proteome Research
Tokyo, Japan – July 25, 2025 – ProteoBridge Inc. (…
Conferences and Exhibitions
Proteo-Bridge Inc. Exhibiting at the Corporate Booth of the “2025 Japan Health JETRO Pavilion”
Proteo-Bridge Inc. is pleased to announce our part…
A-Cube
[New Service Announcement] Launch of Paraneoplastic Neurological Syndrome-Related Antibody Detection Set (Research Use Only)
~ Cutting-edge technology enables simultaneous tes…
award
Certified as an AISol startup.
Proteobridge Co., Ltd. has been certified as an AI…
A-Cube
The 66th Annual Meeting of the Japanese Society of Neurology has begun! We are introducing HuPEX and many other services at our booth.
At our booth, we will introduce the features of ea…
A-Cube
Exhibiting at the 66th Annual Meeting of the Japanese Society of Neurology
Proteobridge Inc. (Headquarters: Tokyo, President …